Screener
AbCellera Biologics Inc. ABCL Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from AbCellera Biologics Inc.’s reported figures.
Based on trailing twelve months.
The source filing: AbCellera Biologics Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:28 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001703057-26-000046
FAQ
- What is AbCellera Biologics Inc.'s net margin?
- AbCellera Biologics Inc. (ABCL) reported net margin of -248.8% in Q2 2026.
- How has AbCellera Biologics Inc.'s net margin changed year-over-year?
- AbCellera Biologics Inc.'s net margin increased by 50.6% year-over-year, from -503.9% to -248.8%.
- What is the long-term trend for AbCellera Biologics Inc.'s net margin?
- Over 4 years (2020 to 2025), AbCellera Biologics Inc.'s net margin has grown at a 39.8% compound annual growth rate (CAGR), from 51% to -194.9%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about AbCellera Biologics Inc.'s net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude